Abstract: |
What is described is a compound having the formula
wherein
-
- R1 is branched alkyl of the structure (CH3(CH2)m)2CH—, wherein m is 2 or 3;
- R2 is a linear alkyl of 1, 2, 3, 4, 5, 6, 7, 8, or 9 carbons, a branched alkyl of 3, 4, 5, 6, 7, 8, or 9 carbons, or an alkenyl or alkynyl of 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 carbons;
- R3 is —(CH2)p—, wherein p is 2, 3, 4, 5 or 6;
- R4 and R5 are the same or different, each a hydrogen, or a linear or branched alkyl of 1, 2, 3, 4, 5 or 6 carbons;
- L1 and L2 are the same or different, of the structure —(CH2)n—, wherein n is 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, or 18;
- L3 is a bond;
- X1 is —CO—O— whereby -L2-CO—O—R2 is formed;
- X2 is S or O; and
- X3 is —CO—O— whereby -L1-CO—O—R1 is formed; and
wherein m+n+p is 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, or 27;
or a pharmaceutically acceptable salt thereof.
|
Inventor: |
Payne, Joseph E. (San Diego, CA, US); Chivukula, Padmanabh (San Diego, CA, US) |
Applicant: |
Arcturus Therapeutics, Inc. (San Diego, CA, US) |
Face Assignee: |
Arcturus Therapeutics, Inc. (San Diego, CA, US) |
Filed: |
2017-11-20 |
Issued: |
2018-04-24 |
Claims: |
20 |
|
US9951002
|
1. A compound of formula 2
(9)
(9)
|
|
11. A compound of formula 2
(6)
(9)
|
|
18. A compound of formula 2
(2)
(10)
|
|